Prevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Egy)

Clinical trial NCT07221331 · RECRUITING

Trial details

NCT number: NCT07221331
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Neurofibromatosis Type 1

Start date: 2025-11-19
Primary completion: 2026-09-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.